From the Provost — May 2, 2018

Pharmacy Dean Henry Mann recommended for reappointment

Dear Colleagues,

I write to advise you that I am pleased to recommend the reappointment of Henry J. Mann, PharmD, FCCP, FCCM, FASHP, as dean of the College of Pharmacy. Pending approval of the Board of Trustees, his second term will begin July 1, 2018, and run through June 30, 2023.

Under Dean Mann’s leadership, the College of Pharmacy has continued to build on its curricular strengths, including broadening the BSPS program, developing a Pharmaceutical Sciences undergraduate minor, and restructuring the PharmD program to focus on student-centered learning that integrates pharmaceutical sciences and clinical pharmacy.

Recognized nationally for its innovative education and research, the college has increased the number of faculty from 58 to 78 since 2013 and has more than doubled total research funding during that same period — from $5.8 million to $12.1 million. Likewise, the college has set records in advancement for the amount of funding it has generated and the number of donors who contribute, making it fifth in the nation for productivity among pharmacy schools.

Its outreach and engagement programs serve an increasingly important role in the community in the face of the national opioid crisis. Generation Rx, now in its 10th year, continues to develop resources to prevent prescription drug abuse, and the telepharmacy Medication Management Program improves treatment outcomes for patients taking numerous prescriptions.

Please join me in congratulating Dean Mann and wishing him continued success in the years to come.


Bruce A. McPheron, PhD
Executive Vice President and Provost